Labeling Pilot for FDF Country of Origin, API Country of Origin, and KSM Country of Origin for Pharmaceutical Products

DLA Troop Support · United States government procurement

Closed September 23, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

1. Purpose

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is conducting market research to identify U.S. or international pharmaceutical manufacturers that are willing to participate in a labeling pilot program. The pilot seeks to explore voluntary inclusion of additional product labeling data for Pharmaceutical Products identifying:

Country of origin for the Finished Dose Form (FDF)
Country of origin for each Active Pharmaceutical Ingredient (API)
Country of origin for each Key starting material (KSM) necessary for the production of each API
Given the amount of information requested, inclusion of a QR code or link to additional information, or other methods of making the information accessible, could be considered
If the country of origin of the API or KSM can vary by lot produced, DLA would be interested in the information specific to the labeled lot and to any previously produced lots

This RFI is issued solely for information and planning purposes. It does not constitute a solicitation, and responses do not commit the Government to any future acquisition or requirement.

2. Background

DLA Troop Support Medical is evaluating methods to improve supply chain transparency, enhance traceability, and strengthen operational readiness by increasing visibility into the sourcing of pharmaceutical ingredients. Understanding FDF, API, and KSM origins helps support contingency planning, risk modeling, and alignment with emerging regulatory and strategic sourcing initiatives.

The agency is exploring the feasibility of obtaining this information directly from manufacturers through voluntary labeling enhancements on packaging, shipping containers, or supplemental documentation.

3. Scope of Pilot

The proposed labeling pilot will focus on a selected subset of generic pharmaceutical products purchased by DLA Troop Support Medical. Participating manufacturers may be asked to provide:

API country of manufacture
API country of origin (if...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyDLA Troop Support
CountryUnited States
CategoryGovernment Procurement
PublishedAugust 24, 2026
Procurement stageSources Sought
ClosedSeptember 23, 2026
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 10, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Browse Similar Open Opportunities in United States

PPVG GEN V Award
PPVG GEN V AWARD SPE2DX25D9000
PPVG GEN V AWARD SPE2DX25D8000
Febuxostat National Contract
Ziprasidone Capsules
Hydrocodone Acetaminophen
Olanzapine SPE2D2-25-D-0011 Award
Furosemide Tablets

See every United States Government Procurement opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Government Procurement intelligence report in your inbox

A personalized report on United States Government Procurement opportunities, emailed in 5-10 minutes. One per month, no account needed.